Medically reviewed by Drugs.com. Last updated on Aug 22, 2022.
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
7T Pharma, LLC
What is Gen7T Lotion® ?
This is a topical lotion consisting of the local anesthetic, lidocaine.
What is Gen7T Lotion® used for?
The lotion is applied topically for use on normal intact skin for temporary relief of pain and itching due to minor cuts, minor scrapes, minor skin irritations, minor burns and insect bites. Read the information sheet provided before you start using this medication and each time you get a refill. If you have any questions, please consult your doctor or pharmacist. Inform your doctor if your condition does not improve or if it worsens. The use of this medication shall be used under the supervision of a physician only as it may be used in conjunction with other therapies.
This information may not include all of the information needed to use Gen7T Lotion® safely and effectively.
For Topical Use Only
What are the possible side effects with Gen7T Lotion®
- Common: itching, redness or flaking of the skin following application (note: the majority of patients experience no significant adverse events following application).
- NOTE: serious side effects are, in general, related to accidental toxicity of medication by applying considerably more than directed by your doctor or pharmacist or by ingesting the contents of the lotion or using this lotion in conjunction with other lidocaine containing products.
- Tell your healthcare provider about all the medicines you take. This includes prescription and nonprescription medicines, vitamins, and herbal supplements
- Avoid excessive alcohol usage, since it may increase the potential for Central Nervous System (CNS) effects such as dizziness, confusion, lightheadedness and orthostatic hypotension.
This is not a complete list of the possible side effects. For more information, talk with your doctor or pharmacist. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
KEEP OUT OF REACH OF CHILDREN
DIRECTIONS FOR USE
Adults and children 12 years and over:
Apply Gen7T Lotion® to intact skin of the affected area. Clean and dry the affected area and apply product direct to the skin, up to 4 times daily. Clothing may be worn over the area of application. If irritation or a burning sensation occurs during application, wash the lotion off the skin and do not reapply until the irritation subsides.
Children under 12 years of age: Consult a doctor
On This Page
1. Do not use:
- On the face or rashes
- On wounds, damaged or infected skin
- On eyes, mouth, genitals, or other mucous membranes
- With a bandage or heating pad
2. Consult physician for children under 12 years of age
3. Stop and consult your prescriber
- If pain worsens
- If you are allergic to any of the ingredients in this product
- If excessive skin irritation develops
- If using concurrently with any other external pain-relieving products
- If you are pregnant, planning to become pregnant, or breastfeeding
- If symptoms persist for more than 7 days, or symptoms clear up and occur again within 3 days
Call your healthcare provider right away if you get any of the following warning signs or any other unusual symptoms that concern you:
- Shortness of breath
- Swelling or numbness of the tongue or throat
- Severe headache or vomiting
- Dizziness or faintness
- Changes in vision or speech
Excessive dosage, or short interval between doses, can result in high plasma levels and serious adverse effects. Patients should be instructed to strictly adhere to the recommended dosage and administration guidelines set forth in this literature and on your prescription label. The management of serious adverse reactions may require the use of resuscitative equipment, oxygen or other resuscitative drugs.
General information about the safe and effective use Gen7T Lotion®
Medicines are sometimes prescribed for purposes other than those listed in a patient information leaflet. Do not use this product for another indication unless instructed and prescribed by a physician. Do not give this drug to anyone else, even if they have the same condition. This product is intended for use as prescribed by a physician.
How should I store Gen7T Lotion®
Store product at room temperature at 68°F to 77°F (20°C to 25°C). Keep away from heat or sunlight. Protect from excessive moisture. Safely discard product after expiration date posted on the product label. Discard this product away from small children or animals.
DO NOT use the product after the expiration date printed on the bottle.
What are the active ingredients in Gen7T Lotion® ?
The lotion consists of 3.5% lidocaine.
Phenoxyethanol, Ethylhexylglycerin, Water, Glycerin, Disodium EDTA, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Caprylic/Capric Triglycerides, Triethanolamine
Gen7T Lotion® is a prescription topical lotion containing 120 grams in a bottle. Lidocaine is present in a 3.5% concentration (w/w). It is chemically designated as 2-(diethylamino)-N-(2,6-dimethylphenyl) acetamide and has an empirical formula of C14H22N2O. The molecular weight of lidocaine is 234.34 g/mol.
The structural formulas are:
Lidocaine is a topical anesthetic and stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action.
Gen7T Lotion® is contraindicated in patients with a known hypersensitivity to lidocaine, or any of the topical amide-like local anesthetic preparations or to any other component of the product.
Because of the possibility of sedation, patients should be cautioned regarding the operation of heavy machinery or automobiles, and any activities made hazardous by decreased alertness.
Hepatic Disease: Patients with severe hepatic disease are at greater risk of developing toxic blood concentrations of Lidocaine, because of their inability to metabolize Lidocaine normally.
Allergic Reactions: Patients allergic to para-aminobenzoic acid derivatives (procaine, tetracaine, benzocaine, etc.) have not shown cross sensitivity to Lidocaine. However, this product should be used with caution in patients with a history of drug sensitivities, especially if the etiologic agent is uncertain.
Non-intact Skin: Application to broken or inflamed skin, although not tested, may result in higher blood concentrations of Lidocaine from increased absorption. Gen7T Lotion® is only recommended for use on intact skin.
Eye Exposure: The contact of this product with the eyes, although not studied, should be avoided based on the findings of severe eye irritations with the use of similar products in animals. If eye contact occurs, immediately wash out the eye with water or saline and protect the eye until sensation returns.
External Heat Sources: Placement of external heat sources, such as heating pads or electric blankets, over application area is not recommended as this has not been evaluated and may increase plasma Lidocaine levels.
Antiarrhythmic Drugs: Gen7T Lotion® should be used with caution in patients receiving Class 1 antiarrhythmic drugs (such as tocainide and mexiletine) since the toxic effects are additive and potentially synergistic.
Local Anesthetics: When Gen7T Lotion® is used concurrently with other products containing local anesthetic agents the amount absorbed from all formulations must be considered.
CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY:
A minor metabolite, 2,6-xylidine, has been found to be carcinogenic in rats. The blood concentration of this metabolite is negligible following application topical lidocaine. The effect of Gen7T Lotion® on fertility has not been studied.
The safety of Gen7T Lotion® has not been established during pregnancy. There are no well-controlled studies in pregnant women. Gen7T Lotion® should not be used during pregnancy unless absolutely needed and discussed with a physician.
The effect of Gen7T Lotion® on the nursing infant has not been evaluated. Caution should be exercised when Gen7T Lotion® is administered to a nursing mother.
PEDIATRIC / GERIATRIC USE:
Safety and effectiveness in pediatric and geriatric patients have not been established.
The most common adverse reactions are application site reactions, including dermatitis, itching or scaling. These tend to be dose-limiting and diminish with time.
Serious adverse experiences following the administration of Gen7T Lotion® are similar in nature to those observed in other amide anesthetic-containing agents. These adverse experiences are, in general, dose-related and may result from high plasma levels caused by excessive dosage, rapid absorption, or may result from hypersensitivity, idiosyncrasy, or a diminished tolerance on the part of the patient. Serious adverse experiences are generally systemic in nature.
There have been no reports of over-dosage with Gen7T Lotion®. Signs of overdosage would include vomiting, drowsiness, coma, respiratory depression, and seizures. In the case of an overdosage, discontinue the product immediately, treat the patient symptomatically, and institute supportive measures.
Gen7T Lotion® is supplied in the following dosage form:
Made in USA
7T Pharma, LLC
220 Emerald Vista Way
Las Vegas, NV 89144
NDC: 70645-627-35 Size: 120 grams
PRINCIPAL DISPLAY PANEL
GEN 7T Lotion
Lidocaine 3.5% Lotion
|Labeler - 7T Pharma LLC (080220022)|
More about Gen7T Lotion (lidocaine topical)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug class: topical anesthetics
- Latest FDA Alerts (7)